Literature DB >> 16627978

Proteomic analysis of hemangioblastoma cyst fluid.

Sven Gläsker1, Alexander O Vortmeyer, Russell R Lonser, Irina A Lubensky, Hiroaki Okamoto, John B Xia, Jie Li, Erin Milne, Jeffrey A Kowalak, Edward H Oldfield, Zhengping Zhuang.   

Abstract

OBJECTIVE: Hemangioblastomas are benign CNS tumors that occur sporadically or in patients with von Hippel-Lindau (VHL) disease. These tumors are characteristically associated with formation of intra- or peritumoral cysts. Hemangioblastoma cyst formation is a major cause of morbidity and mortality with these tumors. While peritumoral cysts have been suggested to result from vascular leakage, the mechanism of intratumoral cyst formation is not understood.
METHODS: To elucidate the origin of intratumoral hemangioblastoma cyst fluid, we characterized its biochemical composition by two-dimensional (2D) proteomic profiling followed by sequencing of several proteins. The proteomic pattern of intratumoral cyst fluid was furthermore compared to the proteomic pattern of serum, hemangioblastoma tumor tissue, and hemangioblastoma peritumoral cyst fluid.
RESULTS: We show that proteomic patterns of intra- and peritumoral cyst fluid are identical Both are highly similar to serum and not to tumor.
CONCLUSIONS: Intratumoral hemangioblastoma cyst fluid originates from serum. Cyst formation associated with hemangioblastoma, whether peri- or intratumoral, is a consequence of vascular leakage. Anti-VEGF therapy may effectively control hemangioblastoma cyst formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627978     DOI: 10.4161/cbt.5.5.2657

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  10 in total

Review 1.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review.

Authors:  Yosef Laviv; Burkhard S Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-07       Impact factor: 3.042

2.  Development of a small solid cerebellar haemangioblastoma into a large pseudocyst with a mural nodule in a patient without VHL; the importance of regular follow-up.

Authors:  Hansol Kim; Jin-Deok Joo; Young-Hoon Kim; Chae-Yong Kim
Journal:  BMJ Case Rep       Date:  2014-11-26

3.  Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease.

Authors:  Joshua J Wind; Kamran D Bakhtian; Jennifer A Sweet; Gautam U Mehta; Jayesh P Thawani; Ashok R Asthagiri; Edward H Oldfield; Russell R Lonser
Journal:  J Neurosurg       Date:  2010-10-08       Impact factor: 5.115

Review 4.  Systemic VHL gene functions and the VHL disease.

Authors:  Hannah L Bader; Tien Hsu
Journal:  FEBS Lett       Date:  2012-04-25       Impact factor: 4.124

Review 5.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

Review 6.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions.

Authors:  Andrii Dinets; Maria Pernemalm; Hanna Kjellin; Vitalijs Sviatoha; Anastasios Sofiadis; C Christofer Juhlin; Jan Zedenius; Catharina Larsson; Janne Lehtiö; Anders Höög
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

8.  Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease.

Authors:  Hiroshi Kanno; Natsuki Kobayashi; Satoshi Nakanowatari
Journal:  J Kidney Cancer VHL       Date:  2014-08-05

9.  Combined transcriptomic and lipidomic analysis reveals aberrant lipid metabolism in central nervous system hemangioblastomas.

Authors:  Qiguang Wang; Wenke Liu; Si Zhang; Zuoyu Liang; Linhong Jiang; Aiqin Xue; Xiaobo Cen; Qian Bu
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

10.  A Challenge in Diagnosis of Cerebellar Hemangioblastoma.

Authors:  Ana Lopes Dos Santos; Sara Trevas; Maria Luiza Rosado
Journal:  Cureus       Date:  2022-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.